News

Moleculin Biotech, Inc.: Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...
Valkea Resources Plans Aggressive Exploration Programs Across Its Northern Finland Project Portfolio
Valkea Resources Corp. (TSXV: OZ) (the "Company" or "Valkea") is pleased to announce exploration plans for an aggressive 2025 field season ...
Richmond Times-Dispatch22h
City officials will not release spending records for employee under investigation
Release of the requested documents will negatively impact an ongoing inspector general investigation,” a city FOIA officer ...